3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
2
Phase 1/2
1
Status
Completed
22
Recruiting
13
Terminated
8
Unknown
5
Not yet recruiting
4
Active not recruiting
3
Withdrawn
1
Suspended
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Dermatologic
1
Conditions
Neoplasms
8
Pancreatic Neoplasms
4
Myelodysplastic Syndromes
3
Melanoma
3
Leukemia, Myeloid, Acute
3
Leukemia
3
Glioblastoma
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
3
Stomach Neoplasms
2
Recurrence
2
Multiple Myeloma
2
Lymphoma, T-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma
2
Lung Neoplasms
2
Colorectal Neoplasms
2
Breast Neoplasms
2
Vaginitis
1
Uterine Cervical Neoplasms
1
Tongue Neoplasms
1
Solid Tumors
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
Drug Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Suspended
×
Lymphoma, T-Cell, Peripheral
×
Clear all
NCT05138458
2023-11-13
IMAGINE
Myeloid Therapeutics
Phase 1/2
Suspended
40 enrolled